Jeremy A. Klein, MD

University of Chicago Medical Center

Poster(s):

• P4399 - Efficacy and Safety of GLP-1 Agonists on Metabolic Parameters in Non-Diabetic Patients With Inflammatory Bowel Disease
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET

• P4400 - Elevation of Liver Enzymes In Patients With Inflammatory Bowel Disease Treated With Upadacitinib Is Associated With Metabolic Risk Factors
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET

• P4452 - Dramatic Changes in Thiopurine Metabolite Levels in a Patient with Inflammatory Bowel Disease Treated with Tirzepatide for Weight Loss: A Case Report
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET

• P4453 - Immediate Hypersensitivity to Intravenous Risankizumab-Rzaa but Subsequent Tolerance to Subcutaneous Risankizumab-Rzaa
  Tuesday, October 29, 2024

  10:30 AM – 4:00 PM ET